by Jen Hodson | Jun 5, 2018 | Events, Press Releases
CULVER CITY, CALIFORNIA, June 5, 2018 - NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that Dr. Patrick Soon-Shiong, Chairman & CEO of NantKwest will be presenting and conducting one-on-one...
by Jen Hodson | May 17, 2018 | Events, Press Releases
CULVER CITY, CA, May 16, 2018 - NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting and conducting one-on-meetings at several investment conferences during the month of...
by Jen Hodson | Apr 23, 2018 | Events, Press Releases
CULVER CITY, CALIFORNIA - April 23, 2018 - NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting at several science and medicine in the month of April and May 2018. The...
by Jen Hodson | Mar 13, 2018 | Events, Press Releases
CULVER CITY, CALIFORNIA - March 13, 2018 - NantKwest (Nasdaq:NK), a leading, clinical-stage natural killer cell based therapeutics company, today announced that the company will be presenting and conducting one-on-one meetings at a number of investment and healthcare...
by Jen Hodson | Feb 13, 2018 | Press Releases
CULVER CITY, Calif.–NantKwest Inc. (Nasdaq:NK), a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat cancer, today announced that the first patient has...
by Jen Hodson | Jan 11, 2018 | Events, Press Releases
To Listen to the Webcast...
